Literature DB >> 11429324

Dendritic cells as a tool to induce anergic and regulatory T cells.

H Jonuleit1, E Schmitt, K Steinbrink, A H Enk.   

Abstract

The induction of antigen-specific T-cell tolerance in the thymus and its maintenance in the periphery is crucial for the prevention of autoimmunity. As well as their stimulatory functions, there is growing evidence that dendritic cells, acting as professional antigen-presenting cells, also maintain and regulate T-cell tolerance in the periphery. This control function is exerted by certain maturation stages and subsets of different ontogeny, and can be influenced by immunomodulatory agents. What is the current state of knowledge of the "immunoregulatory" properties of dendritic cells and how might tolerance-inducing dendritic cells be relevant to therapeutic applications in humans?

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11429324     DOI: 10.1016/s1471-4906(01)01952-4

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  81 in total

Review 1.  Dendritic cell regulation of immune responses: a new role for interleukin 2 at the intersection of innate and adaptive immunity.

Authors:  Francesca Granucci; Ivan Zanoni; Sonia Feau; Paola Ricciardi-Castagnoli
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

2.  Autoantigen-specific protection of non-obese diabetic mice from cyclophosphamide-accelerated diabetes by vaccination with dendritic cells.

Authors:  T Krueger; U Wohlrab; M Klucken; M Schott; J Seissler
Journal:  Diabetologia       Date:  2003-08-20       Impact factor: 10.122

3.  Indoleamine 2,3-dioxygenase and regulatory dendritic cells contribute to the allograft protection induced by infusion of donor-specific splenic stromal cells.

Authors:  Li Liu; Lihua Duan; Min Gong; Hong Dai; Quan Gong; Fang Zheng; Zheng Tan; Congyi Wang; Feili Gong; Min Fang
Journal:  Cell Mol Immunol       Date:  2010-11-08       Impact factor: 11.530

4.  Curcumin induces maturation-arrested dendritic cells that expand regulatory T cells in vitro and in vivo.

Authors:  N M Rogers; S Kireta; P T H Coates
Journal:  Clin Exp Immunol       Date:  2010-12       Impact factor: 4.330

5.  Ex vivo expanded dendritic cells home to T-cell zones of lymphoid organs and survive in vivo after allogeneic bone marrow transplantation.

Authors:  Christoph H Schimmelpfennig; Stephan Schulz; Caroline Arber; Jeanette Baker; Ingo Tarner; Jacqueline McBride; Christopher H Contag; Robert S Negrin
Journal:  Am J Pathol       Date:  2005-11       Impact factor: 4.307

Review 6.  Regulatory T cells in human disease and their potential for therapeutic manipulation.

Authors:  Leonie S Taams; Donald B Palmer; Arne N Akbar; Douglas S Robinson; Zarin Brown; Catherine M Hawrylowicz
Journal:  Immunology       Date:  2006-05       Impact factor: 7.397

7.  Paradoxical effects of interleukin-10 on the maturation of murine myeloid dendritic cells.

Authors:  Dianne L Commeren; Peter L Van Soest; Khalil Karimi; Bob Löwenberg; Jan J Cornelissen; Eric Braakman
Journal:  Immunology       Date:  2003-10       Impact factor: 7.397

Review 8.  CD25+ CD4+ regulatory T-cells in cancer.

Authors:  David C Linehan; Peter S Goedegebuure
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

9.  Surface engineered polymersomes for enhanced modulation of dendritic cells during cardiovascular immunotherapy.

Authors:  Sijia Yi; Xiaohan Zhang; Hussain Sangji; Yugang Liu; Sean D Allen; Baixue Xiao; Sharan Bobbala; Cameron L Braverman; Lei Cai; Peter I Hecker; Mathew DeBerge; Edward B Thorp; Ryan E Temel; Samuel I Stupp; Evan A Scott
Journal:  Adv Funct Mater       Date:  2019-08-12       Impact factor: 18.808

10.  Inhibition of TNF alpha during maturation of dendritic cells results in the development of semi-mature cells: a potential mechanism for the beneficial effects of TNF alpha blockade in rheumatoid arthritis.

Authors:  A W T van Lieshout; P Barrera; R L Smeets; G J Pesman; P L C M van Riel; W B van den Berg; T R D J Radstake
Journal:  Ann Rheum Dis       Date:  2004-07-15       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.